Global X is about to launch a BTC futures strategy ETF, with the code BTRN
According to Golden Finance, Bloomberg ETF analyst James Seyffart stated on social media that Global X's BTC Futures Strategy ETF will be launched on March 21, 2024, with the code BTRN. The Global X BTC Futures Strategy ETF aims to provide investment results corresponding to the price and return performance (minus fees and expenses) of CoinDesk Bitcoin futures index futures ("base index"). According to the prospectus, this fund will invest at least 80% of its total assets plus borrowings for investment purposes (if any) in component stocks of CoinDesk Bitcoin futures index futures and other securities determined by advisors to have economic characteristics essentially identical to those constituting the base index components (such as US-listed Bitcoin futures ETFs). In addition, in order to track relevant indices, this fund may invest in debt securities not included in related indices, cash and cash equivalents or money market instruments such as repurchase agreements and money market funds.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.
TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).
Crypto prices
More
